Literature DB >> 34286012

Assessing Prepulse Inhibition of Startle in Mice.

Christina Ioannidou1,2, Giovanni Marsicano1,2, Arnau Busquets-Garcia1,2.   

Abstract

Animal models are an important tool for studying neuropsychiatric disorders. However, a major challenge for researchers working with laboratory rodents is trying to reproduce 'core' symptoms of complex human disorders such as schizophrenia. Despite this challenge, however, it is still conceivable to use animal models designed to reproduce some of the disease's 'endo-phenotypes'. One example is the prepulse inhibition (PPI) of the startle reflex. PPI is a form of startle plasticity and is characterized by a normal reduction in startle magnitude that occurs when an intense startling stimulus (or pulse) is preceded by a weaker pre-stimulus (or prepulse). The PPI paradigm is commonly used to evaluate sensorimotor gating and it has been described in numerous species including humans and rodents. Deficits in PPI have been observed in subjects with schizophrenia and other neuropsychiatric diseases, as well as in established animal models of these disorders. The PPI paradigm is therefore largely used to explore genetic and neurobiological mechanisms underlying the sensorimotor gating phenotypes found in these disorders. Thus, it is necessary to set up reliable and reproducible protocols to study PPI in mice.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Animal models; PPI; Prepulse inhibition of startle; Schizophrenia; Sensorimotor gating

Year:  2018        PMID: 34286012      PMCID: PMC8275280          DOI: 10.21769/BioProtoc.2789

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  23 in total

1.  Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Authors:  R J Carter; L A Lione; T Humby; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  Behavior and mutagenesis screens: the importance of baseline analysis of inbred strains.

Authors:  L M Tarantino; T J Gould; J P Druhan; M Bucan
Journal:  Mamm Genome       Date:  2000-07       Impact factor: 2.957

3.  Presidential Address, 1974. The more or less startling effects of weak prestimulation.

Authors:  F K Graham
Journal:  Psychophysiology       Date:  1975-05       Impact factor: 4.016

4.  Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response.

Authors:  A E Bullock; B S Slobe; V Vázquez; A C Collins
Journal:  Behav Neurosci       Date:  1997-12       Impact factor: 1.912

5.  Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder.

Authors:  Susanne E Ahmari; Victoria B Risbrough; Mark A Geyer; H Blair Simpson
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

6.  Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania.

Authors:  W Perry; A Minassian; D Feifel; D L Braff
Journal:  Biol Psychiatry       Date:  2001-09-15       Impact factor: 13.382

7.  Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

Authors:  A M Ouagazzal; F Jenck; J L Moreau
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

8.  Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia.

Authors:  D L Braff; M A Geyer; G A Light; J Sprock; W Perry; K S Cadenhead; N R Swerdlow
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

9.  Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition.

Authors:  S B Schwarzkopf; J S Lamberti; D A Smith
Journal:  Biol Psychiatry       Date:  1993 Jun 1-15       Impact factor: 13.382

10.  Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice.

Authors:  A Busquets-Garcia; E Soria-Gómez; B Redon; Y Mackenbach; M Vallée; F Chaouloff; M Varilh; G Ferreira; P-V Piazza; G Marsicano
Journal:  Mol Psychiatry       Date:  2017-02-21       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.